Envestnet Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79M | Buy |
50,753
+6,777
| +15% | +$373K | ﹤0.01% | 2589 |
|
|
2025
Q1 | $3.11M | Sell |
43,976
-1,145
| -3% | -$80.9K | ﹤0.01% | 2437 |
|
|
2024
Q4 | $2.97M | Sell |
45,121
-7,791
| -15% | -$512K | ﹤0.01% | 2454 |
|
|
2024
Q3 | $3.72M | Sell |
52,912
-45,515
| -46% | -$3.2M | ﹤0.01% | 2298 |
|
|
2024
Q2 | $8.1M | Sell |
98,427
-40,055
| -29% | -$3.3M | ﹤0.01% | 1687 |
|
|
2024
Q1 | $12.1M | Sell |
138,482
-17,902
| -11% | -$1.56M | ﹤0.01% | 1407 |
|
|
2023
Q4 | $15.1M | Buy |
156,384
+30,584
| +24% | +$2.95M | 0.01% | 1193 |
|
|
2023
Q3 | $11.1M | Buy |
125,800
+59,095
| +89% | +$5.23M | 0.01% | 1304 |
|
|
2023
Q2 | $5.78M | Buy |
66,705
+8,339
| +14% | +$723K | ﹤0.01% | 1627 |
|
|
2023
Q1 | $5.68M | Buy |
58,366
+2,569
| +5% | +$250K | ﹤0.01% | 1588 |
|
|
2022
Q4 | $5.77M | Buy |
55,797
+213
| +0.4% | +$22K | ﹤0.01% | 1516 |
|
|
2022
Q3 | $4.71M | Buy |
55,584
+1,644
| +3% | +$139K | ﹤0.01% | 1547 |
|
|
2022
Q2 | $4.47M | Sell |
53,940
-9,528
| -15% | -$790K | ﹤0.01% | 1575 |
|
|
2022
Q1 | $4.89M | Sell |
63,468
-91,724
| -59% | -$7.07M | ﹤0.01% | 1614 |
|
|
2021
Q4 | $13.7M | Buy |
155,192
+4,089
| +3% | +$361K | 0.01% | 1024 |
|
|
2021
Q3 | $11.7M | Sell |
151,103
-5,266
| -3% | -$407K | 0.01% | 1057 |
|
|
2021
Q2 | $13M | Sell |
156,369
-3,058
| -2% | -$255K | 0.01% | 987 |
|
|
2021
Q1 | $12M | Buy |
159,427
+9,963
| +7% | +$752K | 0.01% | 946 |
|
|
2020
Q4 | $13.1M | Buy |
149,464
+1,149
| +0.8% | +$101K | 0.01% | 792 |
|
|
2020
Q3 | $11.3M | Buy |
148,315
+5,643
| +4% | +$429K | 0.01% | 772 |
|
|
2020
Q2 | $17.6M | Buy |
142,672
+7,937
| +6% | +$979K | 0.02% | 565 |
|
|
2020
Q1 | $11.4M | Buy |
134,735
+14,853
| +12% | +$1.26M | 0.01% | 634 |
|
|
2019
Q4 | $10.1M | Buy |
119,882
+8,986
| +8% | +$760K | 0.01% | 803 |
|
|
2019
Q3 | $7.47M | Sell |
110,896
-87,074
| -44% | -$5.87M | 0.01% | 880 |
|
|
2019
Q2 | $17M | Buy |
197,970
+31,058
| +19% | +$2.66M | 0.02% | 529 |
|
|
2019
Q1 | $14.8M | Buy |
166,912
+27,364
| +20% | +$2.43M | 0.02% | 543 |
|
|
2018
Q4 | $11.9M | Buy |
+139,548
| New | +$11.9M | 0.02% | 540 |
|
|
2018
Q3 | – | Sell |
-3,679
| Closed | -$346K | – | 1403 |
|
|
2018
Q2 | $346K | Buy |
3,679
+360
| +11% | +$33.9K | ﹤0.01% | 1458 |
|
|
2018
Q1 | $269K | Buy |
3,319
+1,568
| +90% | +$127K | ﹤0.01% | 1451 |
|
|
2017
Q4 | $157K | Buy |
1,751
+446
| +34% | +$40K | ﹤0.01% | 1944 |
|
|
2017
Q3 | $120K | Sell |
1,305
-1,184
| -48% | -$109K | ﹤0.01% | 2020 |
|
|
2017
Q2 | $226K | Sell |
2,489
-95
| -4% | -$8.63K | ﹤0.01% | 1830 |
|
|
2017
Q1 | $227K | Sell |
2,584
-247
| -9% | -$21.7K | ﹤0.01% | 1865 |
|
|
2016
Q4 | $235K | Buy |
2,831
+1
| +0% | +$83 | ﹤0.01% | 1819 |
|
|
2016
Q3 | $262K | Sell |
2,830
-12,307
| -81% | -$1.14M | ﹤0.01% | 1905 |
|
|
2016
Q2 | $1.18M | Buy |
15,137
+1,404
| +10% | +$109K | ﹤0.01% | 1269 |
|
|
2016
Q1 | $1.13M | Buy |
13,733
+1,630
| +13% | +$134K | ﹤0.01% | 1254 |
|
|
2015
Q4 | $1.27M | Buy |
12,103
+741
| +7% | +$77.6K | 0.01% | 1171 |
|
|
2015
Q3 | $1.2M | Buy |
11,362
+449
| +4% | +$47.3K | 0.01% | 1196 |
|
|
2015
Q2 | $1.49M | Sell |
10,913
-2,753
| -20% | -$377K | 0.01% | 1204 |
|
|
2015
Q1 | $1.7M | Buy |
+13,666
| New | +$1.7M | 0.01% | 1050 |
|
|
2014
Q3 | – | Sell |
-86
| Closed | -$5K | – | 2749 |
|
|
2014
Q2 | $5K | Sell |
86
-33
| -28% | -$1.92K | ﹤0.01% | 2264 |
|
|
2014
Q1 | $8K | Buy |
119
+61
| +105% | +$4.1K | ﹤0.01% | 1957 |
|
|
2013
Q4 | $4K | Sell |
58
-293
| -83% | -$20.2K | ﹤0.01% | 2050 |
|
|
2013
Q3 | $25K | Buy |
+351
| New | +$25K | ﹤0.01% | 1405 |
|